Unlocking the therapeutic potential of antiviral RNAi.

dc.contributor.author	Sanchez-David, RY
dc.contributor.author	Maillard, PV
dc.date.accessioned	2021-10-29T09:13:59Z
dc.date.available	2021-10-29T09:13:59Z
dc.date.issued	2021-10-12
dc.identifier.uri	https://qmro.qmul.ac.uk/xmlui/handle/123456789/74859
dc.description.abstract	RNA interference (RNAi) provides antiviral defense in many organisms, including plants, insects, and nematodes. In this issue of Immunity, Fang et al. (2021) utilize designer peptides targeting viral suppressors of RNAi to provide evidence for the relevance of RNAi to antiviral immunity in mammals, also revealing the potential of this approach toward antiviral therapy.	en_US
dc.format.extent	2180 - 2182
dc.language	eng
dc.relation.ispartof	Immunity
dc.title	Unlocking the therapeutic potential of antiviral RNAi.	en_US
dc.type	Article	en_US
dc.identifier.doi	10.1016/j.immuni.2021.09.013
pubs.author-url	https://www.ncbi.nlm.nih.gov/pubmed/34644551	en_US
pubs.issue	10	en_US
pubs.notes	Not known	en_US
pubs.publication-status	Published	en_US
pubs.volume	54	en_US